Filing Details

Accession Number:
0001192482-18-000404
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-17 16:07:06
Reporting Period:
2018-08-15
Accepted Time:
2018-08-17 16:07:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138776 Aevi Genomic Medicine Inc. GNMX Biological Products, (No Disgnostic Substances) (2836) 980217544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247015 J Sol Barer C/o Aevi Genomic Medicine, Inc.
435 Devon Park Drive, Suite 715
Wayne PA 19087
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-15 2,551,020 $0.96 2,551,020 No 4 P Indirect By: Barer & Son Capital LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By: Barer & Son Capital LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,028,032 Direct
Common Stock 153,846 Indirect By: Wife
Common Stock 365,854 Indirect By: Grantor Retained Annuity Trust
Footnotes
  1. The Reporting Person is a member of Barer & Son Capital LLC. As a member he has an economic interest in the assets owned by Barer & Son Capital LLC; however he has no control of the investment or disposition of such assets. Nevertheless, the reported shares may be deemed beneficially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  2. Shares purchased by the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  3. Shares held by the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV.